Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Total Debt (2016 - 2018)

Historic Total Debt for Anaptysbio (ANAB) over the last 4 years, with Q4 2018 value amounting to $625000.0.

  • Anaptysbio's Total Debt fell 9172.51% to $625000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $625000.0, marking a year-over-year decrease of 9172.51%. This contributed to the annual value of $625000.0 for FY2018, which is 9172.51% down from last year.
  • Latest data reveals that Anaptysbio reported Total Debt of $625000.0 as of Q4 2018, which was down 9172.51% from $2.4 million recorded in Q3 2018.
  • In the past 5 years, Anaptysbio's Total Debt registered a high of $13.8 million during Q4 2016, and its lowest value of $625000.0 during Q4 2018.
  • Over the past 4 years, Anaptysbio's median Total Debt value was $6.7 million (recorded in 2017), while the average stood at $7.2 million.
  • Its Total Debt has fluctuated over the past 5 years, first soared by 18164.39% in 2016, then plummeted by 9172.51% in 2018.
  • Anaptysbio's Total Debt (Quarter) stood at $4.9 million in 2015, then soared by 181.64% to $13.8 million in 2016, then crashed by 45.3% to $7.6 million in 2017, then plummeted by 91.73% to $625000.0 in 2018.
  • Its Total Debt was $625000.0 in Q4 2018, compared to $2.4 million in Q3 2018 and $4.1 million in Q2 2018.